This document outlines a presentation on acute coronary syndrome (ACS) given by nursing students. It defines ACS and its types, including unstable angina, NSTEMI, and STEMI. Risk factors, causes, pathophysiology, signs and symptoms, diagnosis, and management of ACS are discussed in detail. The goals of management are to increase blood flow to the heart, decrease oxygen demand, reduce chest pain, and prevent further damage. Pharmacological therapies and revascularization procedures are described for treating different ACS types. Potential complications are also reviewed.
1) Acute coronary syndrome (ACS) includes unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI).
2) ACS results from a reduction in blood supply to the heart muscle such as from a blockage in one of the coronary arteries.
3) Diagnosis involves electrocardiograms, cardiac biomarker tests, and cardiac imaging to determine if the heart muscle has been damaged.
Acute Coronary Syndrome (ACS) refers to a spectrum of clinical presentations caused by acute coronary athero-thrombosis that obstruct myocardial blood flow. This includes ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), and unstable angina. NSTEMI is diagnosed with elevated cardiac biomarkers and detected ischemia on electrocardiograms or stress tests. Treatment involves antithrombotic and anti-ischemic drugs to reduce ischemia and prevent clots. In some cases, coronary angiography and revascularization by percutaneous coronary intervention may be recommended.
Acute coronary syndrome (ACS) refers to any group of symptoms caused by obstruction of the coronary arteries, usually due to a buildup of plaque that ruptures and causes clot formation. The document discusses the types of ACS (STEMI, NSTEMI, unstable angina), symptoms, diagnostic tests, treatment including thrombolysis, and management of complications like pulmonary edema, cardiogenic shock, and ventricular arrhythmias. ACS results from reduced blood flow to heart muscle and can lead to damage if not promptly treated.
Acute coronary syndrome (ACS) refers to a spectrum of conditions caused by reduced blood flow in the coronary arteries. This includes ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina. ACS is usually caused by rupture of atherosclerotic plaque and subsequent thrombus formation, which occludes coronary arteries. Treatment involves antiplatelet therapy such as aspirin and a P2Y12 inhibitor, anticoagulation with heparin, fibrinolytic therapy for STEMI if PCI is not available, and revascularization when possible. Goals are to restore blood flow, prevent complications, and control symptoms.
Coronary artery disease (CAD) is a major cause of death in India. Atherosclerosis underlies most CAD cases. Unstable angina and NSTEMI are types of acute coronary syndrome (ACS) caused by a reduction in oxygen supply to the heart. The clinical presentation of ACS can include chest pain and other symptoms. Diagnosis involves ECG, cardiac biomarkers, and risk stratification. Treatment focuses on anticoagulation, antiplatelet therapy, and revascularization. Myocardial infarction (MI or heart attack) occurs when an atherosclerotic plaque ruptures completely blocking a coronary artery. This leads to necrosis of heart muscle cells. Diagnosis of MI requires specific ECG changes and elevated cardiac
This document discusses the classification, presentation, diagnosis, and treatment of acute coronary syndrome (ACS). ACS results from an imbalance between myocardial oxygen supply and demand due to a thrombotic coronary artery. It is classified as ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), or unstable angina (UA) based on electrocardiogram findings and cardiac biomarker levels. Initial treatment involves oxygen, nitroglycerin, aspirin, a P2Y12 inhibitor, and anticoagulation. STEMI patients should receive reperfusion via primary percutaneous coronary intervention or fibrinolysis if primary PCI cannot be performed in a timely manner.
1) Acute coronary syndrome includes unstable angina and myocardial infarction, characterized by chest pain and elevated cardiac biomarkers.
2) Clinical features include severe, prolonged chest pain that may radiate to other areas, as well as syncope, vomiting, and arrhythmias.
3) Complications include heart failure, arrhythmias like ventricular fibrillation, cardiac rupture, and remodelling. Diagnosis involves ECG, cardiac enzymes, and angiography. Management focuses on reperfusion therapy, anticoagulation, and risk factor reduction.
1) Acute coronary syndrome (ACS) includes unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI).
2) ACS results from a reduction in blood supply to the heart muscle such as from a blockage in one of the coronary arteries.
3) Diagnosis involves electrocardiograms, cardiac biomarker tests, and cardiac imaging to determine if the heart muscle has been damaged.
Acute Coronary Syndrome (ACS) refers to a spectrum of clinical presentations caused by acute coronary athero-thrombosis that obstruct myocardial blood flow. This includes ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), and unstable angina. NSTEMI is diagnosed with elevated cardiac biomarkers and detected ischemia on electrocardiograms or stress tests. Treatment involves antithrombotic and anti-ischemic drugs to reduce ischemia and prevent clots. In some cases, coronary angiography and revascularization by percutaneous coronary intervention may be recommended.
Acute coronary syndrome (ACS) refers to any group of symptoms caused by obstruction of the coronary arteries, usually due to a buildup of plaque that ruptures and causes clot formation. The document discusses the types of ACS (STEMI, NSTEMI, unstable angina), symptoms, diagnostic tests, treatment including thrombolysis, and management of complications like pulmonary edema, cardiogenic shock, and ventricular arrhythmias. ACS results from reduced blood flow to heart muscle and can lead to damage if not promptly treated.
Acute coronary syndrome (ACS) refers to a spectrum of conditions caused by reduced blood flow in the coronary arteries. This includes ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina. ACS is usually caused by rupture of atherosclerotic plaque and subsequent thrombus formation, which occludes coronary arteries. Treatment involves antiplatelet therapy such as aspirin and a P2Y12 inhibitor, anticoagulation with heparin, fibrinolytic therapy for STEMI if PCI is not available, and revascularization when possible. Goals are to restore blood flow, prevent complications, and control symptoms.
Coronary artery disease (CAD) is a major cause of death in India. Atherosclerosis underlies most CAD cases. Unstable angina and NSTEMI are types of acute coronary syndrome (ACS) caused by a reduction in oxygen supply to the heart. The clinical presentation of ACS can include chest pain and other symptoms. Diagnosis involves ECG, cardiac biomarkers, and risk stratification. Treatment focuses on anticoagulation, antiplatelet therapy, and revascularization. Myocardial infarction (MI or heart attack) occurs when an atherosclerotic plaque ruptures completely blocking a coronary artery. This leads to necrosis of heart muscle cells. Diagnosis of MI requires specific ECG changes and elevated cardiac
This document discusses the classification, presentation, diagnosis, and treatment of acute coronary syndrome (ACS). ACS results from an imbalance between myocardial oxygen supply and demand due to a thrombotic coronary artery. It is classified as ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), or unstable angina (UA) based on electrocardiogram findings and cardiac biomarker levels. Initial treatment involves oxygen, nitroglycerin, aspirin, a P2Y12 inhibitor, and anticoagulation. STEMI patients should receive reperfusion via primary percutaneous coronary intervention or fibrinolysis if primary PCI cannot be performed in a timely manner.
1) Acute coronary syndrome includes unstable angina and myocardial infarction, characterized by chest pain and elevated cardiac biomarkers.
2) Clinical features include severe, prolonged chest pain that may radiate to other areas, as well as syncope, vomiting, and arrhythmias.
3) Complications include heart failure, arrhythmias like ventricular fibrillation, cardiac rupture, and remodelling. Diagnosis involves ECG, cardiac enzymes, and angiography. Management focuses on reperfusion therapy, anticoagulation, and risk factor reduction.
Acute chest pain is one of the most common reason for seeking care in the emergency department (10% of all visits)
Only 10-15% of patients with chest pain actually have ACS.
1) The document discusses acute coronary syndromes (ACS), which include STEMI, NSTEMI, and unstable angina. ACS results from a disruption of the atherosclerotic plaque and subsequent formation of an occlusive thrombus.
2) For STEMI, the preferred reperfusion strategies are primary percutaneous coronary intervention (PCI) within 90 minutes or fibrinolytic therapy within 30 minutes of hospital arrival. For NSTEMI, an early invasive strategy is recommended for high-risk patients.
3) Core pharmacologic therapies for ACS include aspirin, a P2Y12 inhibitor, anticoagulation, and secondary prevention medications like statins. Goals are to restore blood flow, prevent complications,
This document provides an overview of acute myocardial infarction (MI), also known as a heart attack. It discusses the definition, causes, risk factors, pathogenesis, classification, diagnosis and management of MI. The diagnosis involves taking a patient history, examining signs and symptoms, electrocardiography, serum analysis and echocardiography. Management is staged and involves pre-hospital, emergency department and post-discharge care, with a focus on reperfusing the blocked artery as quickly as possible, such as through percutaneous coronary intervention or thrombolytic therapy. The goal is to correctly identify the type of MI, treat the patient according to guidelines and manage any complications.
The document discusses Acute Coronary Syndrome (ACS), which includes Unstable Angina/Non-ST-segment elevation myocardial infarction (UA/NSTEMI) and ST-segment elevation myocardial infarction (STEMI). UA/NSTEMI is caused by a reduction in oxygen supply or increase in demand due to plaque rupture or spasm. STEMI occurs when there is complete thrombotic occlusion of a coronary artery. Both involve chest pain but STEMI presents with ST-segment elevation on ECG. Treatment for both includes anti-ischemic, anti-thrombotic medications, and coronary revascularization if high-risk features are present.
This document discusses acute coronary syndromes and ischemic heart disease. It begins with an overview of heart anatomy and physiology. It then defines acute coronary syndrome and myocardial infarction, describing signs and symptoms. Risk factors for ischemic heart disease are outlined. The document concludes with descriptions of nursing assessments, diagnoses, and interventions for patients with acute coronary syndromes or ischemic heart disease, focusing on pain management, improving perfusion, and reducing anxiety through education.
The document discusses the current management of acute coronary syndrome in a non-interventional center. It outlines the definitions, processes of care, guidelines, and goals in diagnosing and treating ACS in the emergency department and hospital phases, including use of ECG, cardiac markers, medications, risk stratification, and addressing complications.
ACUTE CORONARY SYNDROME FOR CRITICAL CAREAbhinovKandur
The document defines acute coronary syndrome (ACS) as a group of diseases including unstable angina, myocardial infarction, and sudden cardiac death. ACS is classified into STEMI, NSTEMI, or unstable angina based on ECG and cardiac biomarker findings. The diagnosis of ACS involves taking a medical history, performing an ECG, and measuring cardiac biomarkers like troponin and CK-MB. Treatment involves pain relief medications, antiplatelet drugs, anticoagulants, and sometimes revascularization through procedures like angioplasty.
GEMC - Acute Coronary Syndrome - for NursesOpen.Michigan
This document provides an overview of acute coronary syndrome (ACS) including its causes, types, risk factors, signs and symptoms, diagnosis, and treatment. It discusses the different types of ACS such as unstable angina, STEMI, and NSTEMI. For STEMI and NSTEMI it outlines the diagnostic criteria and treatments including medications, procedures, and lifestyle modifications. It also summarizes heart failure, right ventricular infarction, pulmonary edema, and cardiomyopathy.
Acute coronary syndrome presentation with bivalirudinRaleifoot Chisolm
This document summarizes the key steps in treating a patient experiencing an ST-elevation myocardial infarction (STEMI). It describes how inflammatory processes can destabilize atherosclerotic plaques and potentially cause rupture. It then outlines the symptoms, diagnostic criteria, treatment options including percutaneous coronary intervention, and goals for rapid treatment times for STEMI patients.
This document discusses acute coronary syndrome and thrombolytic therapy for STEMI. It defines ACS as a spectrum ranging from unstable angina to STEMI depending on the degree of coronary occlusion. For STEMI, the goals of early management are pain relief, early reperfusion, and treating complications to minimize heart muscle loss. Thrombolytic therapy with drugs like streptokinase or tenecteplase is recommended if initiated within 12 hours of symptoms to restore blood flow. Factors that indicate successful reperfusion and guidelines for concomitant medications, complications, and contraindications to thrombolysis are also summarized.
The document discusses acute coronary syndrome (ACS), which includes unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI). It focuses on angina pectoris, describing the three main types as stable angina, unstable angina, and Prinzmetal angina. Risk factors for angina are discussed, including modifiable factors like hypertension, smoking, and high cholesterol. The pathophysiology of angina and differences between NSTEMI, STEMI, and unstable angina are summarized.
Acute coronary syndrome (ACS) refers to a range of conditions caused by reduced blood flow in the coronary arteries. It includes unstable angina and myocardial infarction (MI or heart attack). Unstable angina is characterized by new or worsening chest pain not relieved by rest or nitroglycerin. MI occurs when an area of heart muscle dies due to complete blockage of a coronary artery. The ECG can detect patterns of ischemia, injury, or infarction and is used to differentiate ACS types. ST elevation MI (STEMI) shows elevated ST segments while non-ST elevation MI (NSTEMI) shows ST depression or T wave changes. Prompt treatment is important to limit heart muscle damage from ACS.
A brief description for 2nd year MBBS students about IHD- MI,Unstable Angina by Dr Sabu Augustine. content from other presentations (ppts)and text books
This document provides an overview of acute coronary syndrome (ACS). It begins with a review of coronary artery anatomy and variations. It then discusses the presentations of ACS, including ischemic chest pain and equivalents. The main types of ACS - unstable angina, NSTEMI, and STEMI - are defined based on symptoms, electrocardiogram findings, and cardiac biomarker levels. Diagnosis and management strategies are outlined, including reperfusion therapies and drug treatments. Follow-up care after ACS and indications for procedures like cardiac catheterization and ICD placement are also summarized.
Acute coronary syndrome (ACS) results from an imbalance between myocardial oxygen supply and demand due to diminished blood flow from an occlusive coronary artery thrombus. ACS is classified as ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation ACS (NSTE-ACS), which includes non-STEMI and unstable angina. Treatment involves antiplatelet and anticoagulant medications, revascularization procedures like percutaneous coronary intervention (PCI), and lifestyle modifications to prevent recurrent events.
This document discusses coronary artery disease (CAD) and myocardial infarction (MI). It covers traditional and emerging risk factors for CAD, the pathophysiology and clinical spectrum of ischemic heart disease, clinical features of angina and acute coronary syndromes, diagnostic testing including ECG and cardiac biomarkers, and treatment strategies including reperfusion therapy, antiplatelet agents, statins, and thrombolysis. The goal of treatment is rapid reperfusion of occluded arteries through primary percutaneous coronary intervention (PCI) or thrombolysis to reduce heart muscle damage.
1. Acute coronary syndrome is defined as myocardial ischemia due to myocardial infarction (NSTEMI or STEMI) or unstable angina.
2. Unstable angina is defined as angina at rest, new onset exertional angina (<2 months), recent acceleration of angina (<2 months), or post revascularization angina.
3. The diagnosis of acute coronary syndrome is based on history, physical exam, ECG, and cardiac enzymes, and patients can then be divided into several groups including stable angina, unstable angina, and myocardial infarction.
1) STEMI/acute coronary syndrome occurs when blood supply to the heart is disrupted, damaging heart muscle. It is caused by blockages in the coronary arteries from clot formations.
2) Symptoms include chest pain that may radiate to the back, neck, or arms along with shortness of breath, nausea and weakness.
3) Risk factors include age over 45, smoking, high blood pressure, high cholesterol, diabetes and obesity.
This document provides an overview of acute coronary syndrome (ACS). It defines ACS as a spectrum ranging from ST-elevation myocardial infarction (STEMI) to non-ST-elevation myocardial infarction (NSTEMI) or unstable angina. The causes of ACS are typically atherosclerotic plaque rupture or erosion that leads to coronary thrombosis. Risk factors, symptoms, diagnostic criteria, types of ACS, treatment algorithms, and management strategies are discussed in detail. The goals are to differentiate between STEMI and NSTEMI, understand appropriate initial treatment for each, and recognize ECG patterns that indicate location and severity of injury.
Pharmacotherapy of ischemic heart diseasetolcha regasa
This document provides an overview of ischemic heart disease (IHD). It defines IHD and divides it into stable angina and acute coronary syndrome (ACS), with ACS further divided into non-ST-segment elevation myocardial infarction (NSTEMI)/unstable angina (UA) and ST-segment elevation myocardial infarction (STEMI). The causes of ACS are also discussed, with plaque rupture being identified as the predominant cause in over 90% of patients. Clinical features, diagnostic workup, and treatment approaches for the different classifications of IHD are described.
This document provides an overview of ischemic heart disease (IHD). It defines IHD as a syndrome arising from an imbalance between oxygen supply and demand in the myocardium. IHD is broadly divided into stable angina and acute coronary syndrome (ACS). ACS includes non-ST-segment elevation myocardial infarction (NSTEMI), unstable angina (UA), and ST-segment elevation myocardial infarction (STEMI). The document discusses the causes, pathogenesis, clinical features, diagnosis, and treatment of these IHD conditions.
Acute chest pain is one of the most common reason for seeking care in the emergency department (10% of all visits)
Only 10-15% of patients with chest pain actually have ACS.
1) The document discusses acute coronary syndromes (ACS), which include STEMI, NSTEMI, and unstable angina. ACS results from a disruption of the atherosclerotic plaque and subsequent formation of an occlusive thrombus.
2) For STEMI, the preferred reperfusion strategies are primary percutaneous coronary intervention (PCI) within 90 minutes or fibrinolytic therapy within 30 minutes of hospital arrival. For NSTEMI, an early invasive strategy is recommended for high-risk patients.
3) Core pharmacologic therapies for ACS include aspirin, a P2Y12 inhibitor, anticoagulation, and secondary prevention medications like statins. Goals are to restore blood flow, prevent complications,
This document provides an overview of acute myocardial infarction (MI), also known as a heart attack. It discusses the definition, causes, risk factors, pathogenesis, classification, diagnosis and management of MI. The diagnosis involves taking a patient history, examining signs and symptoms, electrocardiography, serum analysis and echocardiography. Management is staged and involves pre-hospital, emergency department and post-discharge care, with a focus on reperfusing the blocked artery as quickly as possible, such as through percutaneous coronary intervention or thrombolytic therapy. The goal is to correctly identify the type of MI, treat the patient according to guidelines and manage any complications.
The document discusses Acute Coronary Syndrome (ACS), which includes Unstable Angina/Non-ST-segment elevation myocardial infarction (UA/NSTEMI) and ST-segment elevation myocardial infarction (STEMI). UA/NSTEMI is caused by a reduction in oxygen supply or increase in demand due to plaque rupture or spasm. STEMI occurs when there is complete thrombotic occlusion of a coronary artery. Both involve chest pain but STEMI presents with ST-segment elevation on ECG. Treatment for both includes anti-ischemic, anti-thrombotic medications, and coronary revascularization if high-risk features are present.
This document discusses acute coronary syndromes and ischemic heart disease. It begins with an overview of heart anatomy and physiology. It then defines acute coronary syndrome and myocardial infarction, describing signs and symptoms. Risk factors for ischemic heart disease are outlined. The document concludes with descriptions of nursing assessments, diagnoses, and interventions for patients with acute coronary syndromes or ischemic heart disease, focusing on pain management, improving perfusion, and reducing anxiety through education.
The document discusses the current management of acute coronary syndrome in a non-interventional center. It outlines the definitions, processes of care, guidelines, and goals in diagnosing and treating ACS in the emergency department and hospital phases, including use of ECG, cardiac markers, medications, risk stratification, and addressing complications.
ACUTE CORONARY SYNDROME FOR CRITICAL CAREAbhinovKandur
The document defines acute coronary syndrome (ACS) as a group of diseases including unstable angina, myocardial infarction, and sudden cardiac death. ACS is classified into STEMI, NSTEMI, or unstable angina based on ECG and cardiac biomarker findings. The diagnosis of ACS involves taking a medical history, performing an ECG, and measuring cardiac biomarkers like troponin and CK-MB. Treatment involves pain relief medications, antiplatelet drugs, anticoagulants, and sometimes revascularization through procedures like angioplasty.
GEMC - Acute Coronary Syndrome - for NursesOpen.Michigan
This document provides an overview of acute coronary syndrome (ACS) including its causes, types, risk factors, signs and symptoms, diagnosis, and treatment. It discusses the different types of ACS such as unstable angina, STEMI, and NSTEMI. For STEMI and NSTEMI it outlines the diagnostic criteria and treatments including medications, procedures, and lifestyle modifications. It also summarizes heart failure, right ventricular infarction, pulmonary edema, and cardiomyopathy.
Acute coronary syndrome presentation with bivalirudinRaleifoot Chisolm
This document summarizes the key steps in treating a patient experiencing an ST-elevation myocardial infarction (STEMI). It describes how inflammatory processes can destabilize atherosclerotic plaques and potentially cause rupture. It then outlines the symptoms, diagnostic criteria, treatment options including percutaneous coronary intervention, and goals for rapid treatment times for STEMI patients.
This document discusses acute coronary syndrome and thrombolytic therapy for STEMI. It defines ACS as a spectrum ranging from unstable angina to STEMI depending on the degree of coronary occlusion. For STEMI, the goals of early management are pain relief, early reperfusion, and treating complications to minimize heart muscle loss. Thrombolytic therapy with drugs like streptokinase or tenecteplase is recommended if initiated within 12 hours of symptoms to restore blood flow. Factors that indicate successful reperfusion and guidelines for concomitant medications, complications, and contraindications to thrombolysis are also summarized.
The document discusses acute coronary syndrome (ACS), which includes unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI). It focuses on angina pectoris, describing the three main types as stable angina, unstable angina, and Prinzmetal angina. Risk factors for angina are discussed, including modifiable factors like hypertension, smoking, and high cholesterol. The pathophysiology of angina and differences between NSTEMI, STEMI, and unstable angina are summarized.
Acute coronary syndrome (ACS) refers to a range of conditions caused by reduced blood flow in the coronary arteries. It includes unstable angina and myocardial infarction (MI or heart attack). Unstable angina is characterized by new or worsening chest pain not relieved by rest or nitroglycerin. MI occurs when an area of heart muscle dies due to complete blockage of a coronary artery. The ECG can detect patterns of ischemia, injury, or infarction and is used to differentiate ACS types. ST elevation MI (STEMI) shows elevated ST segments while non-ST elevation MI (NSTEMI) shows ST depression or T wave changes. Prompt treatment is important to limit heart muscle damage from ACS.
A brief description for 2nd year MBBS students about IHD- MI,Unstable Angina by Dr Sabu Augustine. content from other presentations (ppts)and text books
This document provides an overview of acute coronary syndrome (ACS). It begins with a review of coronary artery anatomy and variations. It then discusses the presentations of ACS, including ischemic chest pain and equivalents. The main types of ACS - unstable angina, NSTEMI, and STEMI - are defined based on symptoms, electrocardiogram findings, and cardiac biomarker levels. Diagnosis and management strategies are outlined, including reperfusion therapies and drug treatments. Follow-up care after ACS and indications for procedures like cardiac catheterization and ICD placement are also summarized.
Acute coronary syndrome (ACS) results from an imbalance between myocardial oxygen supply and demand due to diminished blood flow from an occlusive coronary artery thrombus. ACS is classified as ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation ACS (NSTE-ACS), which includes non-STEMI and unstable angina. Treatment involves antiplatelet and anticoagulant medications, revascularization procedures like percutaneous coronary intervention (PCI), and lifestyle modifications to prevent recurrent events.
This document discusses coronary artery disease (CAD) and myocardial infarction (MI). It covers traditional and emerging risk factors for CAD, the pathophysiology and clinical spectrum of ischemic heart disease, clinical features of angina and acute coronary syndromes, diagnostic testing including ECG and cardiac biomarkers, and treatment strategies including reperfusion therapy, antiplatelet agents, statins, and thrombolysis. The goal of treatment is rapid reperfusion of occluded arteries through primary percutaneous coronary intervention (PCI) or thrombolysis to reduce heart muscle damage.
1. Acute coronary syndrome is defined as myocardial ischemia due to myocardial infarction (NSTEMI or STEMI) or unstable angina.
2. Unstable angina is defined as angina at rest, new onset exertional angina (<2 months), recent acceleration of angina (<2 months), or post revascularization angina.
3. The diagnosis of acute coronary syndrome is based on history, physical exam, ECG, and cardiac enzymes, and patients can then be divided into several groups including stable angina, unstable angina, and myocardial infarction.
1) STEMI/acute coronary syndrome occurs when blood supply to the heart is disrupted, damaging heart muscle. It is caused by blockages in the coronary arteries from clot formations.
2) Symptoms include chest pain that may radiate to the back, neck, or arms along with shortness of breath, nausea and weakness.
3) Risk factors include age over 45, smoking, high blood pressure, high cholesterol, diabetes and obesity.
This document provides an overview of acute coronary syndrome (ACS). It defines ACS as a spectrum ranging from ST-elevation myocardial infarction (STEMI) to non-ST-elevation myocardial infarction (NSTEMI) or unstable angina. The causes of ACS are typically atherosclerotic plaque rupture or erosion that leads to coronary thrombosis. Risk factors, symptoms, diagnostic criteria, types of ACS, treatment algorithms, and management strategies are discussed in detail. The goals are to differentiate between STEMI and NSTEMI, understand appropriate initial treatment for each, and recognize ECG patterns that indicate location and severity of injury.
Pharmacotherapy of ischemic heart diseasetolcha regasa
This document provides an overview of ischemic heart disease (IHD). It defines IHD and divides it into stable angina and acute coronary syndrome (ACS), with ACS further divided into non-ST-segment elevation myocardial infarction (NSTEMI)/unstable angina (UA) and ST-segment elevation myocardial infarction (STEMI). The causes of ACS are also discussed, with plaque rupture being identified as the predominant cause in over 90% of patients. Clinical features, diagnostic workup, and treatment approaches for the different classifications of IHD are described.
This document provides an overview of ischemic heart disease (IHD). It defines IHD as a syndrome arising from an imbalance between oxygen supply and demand in the myocardium. IHD is broadly divided into stable angina and acute coronary syndrome (ACS). ACS includes non-ST-segment elevation myocardial infarction (NSTEMI), unstable angina (UA), and ST-segment elevation myocardial infarction (STEMI). The document discusses the causes, pathogenesis, clinical features, diagnosis, and treatment of these IHD conditions.
This document provides information on a seminar about coronary artery disease presented by Ms. Umadevi. K. It defines coronary artery disease as a narrowing of the coronary arteries that limits blood supply to the heart muscle. Risk factors include conditions like high cholesterol, smoking, hypertension, and diabetes. Symptoms include chest pain and diagnostic tests involve ECGs, cardiac enzymes, echocardiograms, and angiography. Treatment includes medications, angioplasty, stents, bypass surgery, lifestyle changes, and managing risk factors.
The document discusses acute coronary syndrome (ACS), which occurs when a plaque in the coronary arteries ruptures and causes blockage. It describes the signs and symptoms of ACS, including chest pain. Diagnosis involves electrocardiograms, blood tests of cardiac markers, and potentially coronary angiography. The document separates ACS into categories - those with and without ST elevation. Treatment aims to break up blood clots and reopen blocked arteries using medications, angioplasty, or coronary bypass surgery.
1. Acute coronary syndromes occur when an atheromatous plaque ruptures in a coronary artery, causing a blood clot that blocks blood flow to the heart. This document discusses the signs, symptoms, diagnosis and treatment of the three main types of acute coronary syndromes: unstable angina, myocardial infarction without ST-elevation, and myocardial infarction with ST-elevation.
2. For diagnosis, electrocardiograms, blood tests of cardiac marker enzymes, and coronary angiography are used to determine if and where the blood flow in the heart is blocked. Treatment involves antiplatelet drugs, anticoagulants, and procedures to reopen blocked arteries such as angioplasty or coronary artery bypass surgery. The
This document provides information on a seminar about coronary artery disease presented by Ms. Umadevi. K. It discusses what coronary artery disease is, its causes, risk factors, signs and symptoms, diagnostic tests, complications and management. The key points are that coronary artery disease is caused by a narrowing of the arteries that limits blood supply to the heart, usually from atherosclerosis. It outlines modifiable risk factors like smoking, obesity, and high cholesterol as well as non-modifiable factors like age and family history. Diagnosis involves tests like ECGs, stress tests, and angiography. Treatment focuses on lifestyle changes, medications, angioplasty, stents, and bypass surgery.
The document summarizes information about coronary artery disease (CAD) presented in a seminar. CAD is caused by a narrowing of the coronary arteries due to atherosclerosis, limiting blood supply to the heart. It can progress to damage heart muscle and lead to complications like infarction, arrhythmias, and heart failure. Risk factors include high cholesterol, smoking, hypertension, diabetes, and family history. Diagnosis involves tests like ECGs, stress tests, imaging, and angiography. Treatment includes medications, angioplasty, stents, bypass surgery, and lifestyle changes.
This document provides an overview of the approach to chest pain and STEMI. It discusses the objectives, epidemiology, causes, clinical presentation, diagnostic workup and management. Regarding causes of chest pain, it classifies them into myocardial ischemia, other cardiopulmonary causes, and non-cardiopulmonary causes. The clinical evaluation priorities acute chest pain patients are clinical stability and probability of life-threatening underlying issues like ACS. Diagnostic testing includes ECG, cardiac biomarkers like troponin and CK-MB to diagnose STEMI.
This document discusses the pathophysiology of myocardial ischemia and infarction. It describes how myocardial oxygen demand can exceed supply, leading to ischemia. Factors that determine oxygen demand and supply are explored, including heart rate, contractility, wall tension, coronary blood flow, oxygen carrying capacity of blood, and autoregulatory resistance in arterioles. The progression and vulnerability of atherosclerotic plaque is summarized. Clinical syndromes like stable angina and acute coronary syndromes (unstable angina and myocardial infarction) are defined and their presentations, diagnoses, and treatment approaches are overviewed.
ISCHEMIA HEART DISEASE AND MYOCARDIAL INFARETIONfikri asyura
This document discusses ischemic heart disease and myocardial infarction. It covers the pathophysiology of coronary ischemia, including how myocardial oxygen demand and supply are determined. When demand exceeds supply, ischemia occurs. The document details the physiology of coronary blood flow, autoregulation, and flow reserve. It then covers the clinical syndromes of stable angina, unstable angina, and acute myocardial infarction. Key concepts include the progression of atherosclerotic plaque, the vulnerable plaque that can rupture in acute coronary syndromes, and the treatment approaches for stable and unstable ischemia.
This document discusses STEMI (ST-elevation myocardial infarction). It defines STEMI as irreversible necrosis of heart muscle due to prolonged ischemia. The pathophysiology section explains how ischemia develops and the factors that determine infarct size. Clinical presentation includes symptoms like chest pain and potential physical exam findings. The workup involves an ECG, cardiac biomarkers, and potentially cardiac imaging. Treatment involves aspirin, nitrates, beta blockers, and anticoagulants with the goals of relieving symptoms and initiating reperfusion therapy.
1) Myocardial infarction occurs when blood supply to the heart is interrupted, causing heart muscle cell death. This is commonly due to a blockage in a coronary artery from a ruptured atherosclerotic plaque.
2) Risk factors include diabetes, smoking, high cholesterol, high blood pressure, family history of heart disease, obesity, stress, and older age.
3) Symptoms include chest pain, shortness of breath, sweating, weakness and nausea. Diagnosis involves electrocardiograms, cardiac enzyme levels and imaging tests.
This document summarizes a seminar on coronary artery disease presented by Ms. Umadevi. K. It defines coronary artery disease as a narrowing of the coronary arteries that limits blood supply to the heart muscle. Risk factors include high cholesterol, smoking, hypertension, diabetes, and family history. Signs and symptoms include chest pain. Diagnosis involves ECGs, cardiac enzymes tests, echocardiograms, stress tests, and angiography. Treatment includes medications, angioplasty, stents, and bypass surgery to restore blood flow.
This document provides objectives and content for an EMS training module covering angina, acute myocardial infarction (MI), and acute stroke. It aims to describe the pathophysiology and presentations of these conditions, including atypical presentations in certain patient populations. Key topics include the development and types of acute MIs, diagnostic tools like electrocardiograms and cardiac markers, differential diagnoses for chest pain, and considerations around diagnosing cardiac conditions in the field.
Coronary artery disease, also known as coronary heart disease, is caused by a narrowing of the coronary arteries due to atherosclerosis. This limits adequate blood flow to the heart muscle and can damage the heart tissue. Symptoms may include chest pain, arrhythmias, and heart failure. Risk factors include high cholesterol, smoking, hypertension, diabetes, obesity, and family history. Treatment involves lifestyle changes, medications, angioplasty, stents, or coronary artery bypass grafting depending on the severity of disease.
1) Acute myocardial infarction is irreversible necrosis of heart muscle caused by prolonged ischemia and can present as unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) or ST-elevation myocardial infarction (STEMI).
2) UA/NSTEMI is diagnosed based on symptoms of chest pain or discomfort and elevated cardiac biomarkers showing myocardial necrosis.
3) Treatment involves reducing myocardial oxygen demands, improving supply, and risk stratification to determine need for aggressive versus conservative management. High risk patients may receive early invasive procedures while low risk patients can be managed medically.
This document discusses the pathophysiology of unstable angina and NSTEMI. It begins by explaining that these conditions result from an imbalance between myocardial oxygen supply and demand, usually presenting as angina with minimal exertion or at rest. Potential causes include arterial spasm, atherosclerosis, coronary artery dissection, or conditions altering myocardial demand/supply like emotion or hypertension. The most frequent mechanism is rupture of an atherosclerotic plaque, exposing thrombogenic tissue and activating the coagulation cascade, resulting in transient thrombosis. Diagnosis involves risk stratification using factors like the TIMI and GRACE scores to predict adverse events and guide management.
The document discusses cardiac function and testing, focusing on coronary artery disease (CAD) and acute coronary syndrome (ACS). It describes how the heart works normally and what goes wrong in CAD and ACS. Key points include: the heart has electrical and mechanical properties to pump blood through the body; CAD occurs when coronary arteries narrow from atherosclerosis, limiting blood flow; ACS occurs when not enough blood reaches the heart due to a blockage from a plaque rupture; electrocardiograms and cardiac biomarkers help diagnose ACS and determine its type and severity.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Acute coronary syndrome
1. UNIVERSITY OF GONDAR
COLLEGE OF MEDICINE AND HEALTH SCIENCES
SCHOOL OF NURSING
DEPARTMENT OF EMERGENCY AND CRITICAL CARE
NURSING
Medical Emergency Seminar Presntation
Title: Acute Coronary Syndrome
Presenter:
April/2021
2. Presentation Outline
Definition
Types of ACS
Epidemiology of ACS
Risk factors
Causes of ACS
Pathophysiology
Clinical manifestations
Dx/investigations
DDx
Management
Complications
8/9/2021
By: 1st Yr MSc EMCCN students 2
3. Objectives
After this presentation you will be able
to:
List the causes/risk factors of ACS
Describe the pathophysiology of ACS
Discuss the clinical features of ACS
Explain management modalities of ACS
Describe the approach to a patient with ACS
Manage a patient with ACS
Dispose a patient with ACS
8/9/2021 By: 1st Yr MSc EMCCN students 3
4. Definition
Ischemic heart disease/CAD is an imbalance in
myocardial oxygen demand and supply resulting
from insufficient blood flow almost always
caused by coronary atherosclerotic disease.
IHD/CAD fall in to two subtypes:-
1-Chronic coronary artery disease/stable
angina
Predictable and consistent pain on exertion(2-
5minutes).
2-ACS-Aute myocardial infarction/Unstable angina
Coronary vessel atherosclerotic obstruction with
acute superimposed thrombotic occlusion.
8/9/2021 By: 1st Yr MSc EMCCN students 4
5. Types of ACS
Unstable Angina-Symptoms of myocardial
ischemia but no elevation in cardiac enzymes,
with or without ECG changes indicative of
ischemia.
It is considered to be present in the following
circumstances:
Rest angina >20 minutes in duration
New onset angina & no response to nitrates
Increasing angina- more frequent or longer in
duration, severe or occurs with less exertion
than previous angina.
8/9/2021 By: 1st Yr MSc EMCCN students 5
6. Type Cont…
Acute Myocardial Infarction (STEMI and NSTEMI)
The term ACS is clinically used because the initial
presentation, Pathophysiology and early
management of unstable angina, STEMI, and
NSTEMI are frequently similar.
MI is necrosis of myocardium as a result of an
interruption of blood supply to the coronary artery.
Myocardial cell death resulting from hypoxia.
WHO criteria for MI are:
Clinical history (>20 minutes of chest discomfort
or equivalent symptoms consistent with
ischemia),
EKG changes, and/or
Elevated myocardial serum markers.
8/9/2021 By: 1st Yr MSc EMCCN students 6
7. Type Cont…
NSTEMI: No ST elevation on ECG (other ECG
evidence of ischemia may be present), elevated
cardiac enzymes and symptoms of myocardial
ischemia.
Results from ischemia that extends only to the
subendocardium.
The distinction between Unstable angina and
NSTEMI is based entirely on cardiac enzymes.
The latter has elevation of troponin or creatine
kinase-MB (CK-MB). Both lack ST-segment
elevations.
8/9/2021 By: 1st Yr MSc EMCCN students 7
8. Type Cont…
STEMI: Significant ST elevation or new left
bundle branch block (LBBB) on ECG, elevated
cardiac enzymes (Troponin and/or CKMB) and
symptoms of myocardial ischemia(Transmural).
The sudden rupture of a plaque and the
subsequent thrombosis are responsible for ACS.
Transmural: shifted in the direction of the outer
(epicardial) layers.
ST elevation >2 mm contiguous chest leads V1–
V6.
ST elevation >1 mm contiguous limb leads I,
aVL, II, III, aVF, aVR.
New LBBB.
8/9/2021 By: 1st Yr MSc EMCCN students 8
13. Epidemiology
Globally, ischemic heart disease remains the
number one cause of mortality
Race ( higher in African American )
Sex- male >women
IHD causes more deaths and disability and
incurs greater economic costs than any other
illness in the developed world.
8/9/2021 By: 1st Yr MSc EMCCN students 13
14. Risk factors for ACS
Modifiable risk factor
Saturated fat diet/dyslipidemia- LDL>100,
HDL<40)
Physical inactivity
Tobacco and alcohol
Over weight or obese
Co-existing diseases- DM, HTN
Non modifiable risk factors
Family history
Age over 65 years
Sex-men higher risk
Preexisting disease/ past history of chronic
8/9/2021 By: 1st Yr MSc EMCCN students 14
15. Causes of ACS
The major cause of MI is coronary artery
occlusion by thrombosis or atheroma.
Inflammation of the coronary arteries (rare)
A stab wound to the heart
A blood clot forming elsewhere in the body
Complications from heart surgery
Coronary artery Spasm( variant angina)
congenital abnormalities (rare)
8/9/2021 By: 1st Yr MSc EMCCN students 15
16. Causes Cont…
Decreased myocardial oxygen supply
a) Coronary artery occlusion- resulting from
atherosclerosis of coronary arteries, coronary
artery spasm, dissection, arteritis, and embolism.
b) Decreased coronary artery perfusion
pressure- as a result of hypotension, shock, or
aortic regurgitation.
Increased myocardial oxygen demand can be
due to many causes- hypertension, hypertrophy,
aortic stenosis, tachycardia/tachyarrhythmia,
infection, surgery, thyrotoxicosis and emotional
or physical stress.
8/9/2021 By: 1st Yr MSc EMCCN students 16
19. Signs and symptoms of ACS
Symptoms
Angina- pain of cardiac origin/chest pain due to
ischemia/imbalance between oxygen demand
and supply.
Pain character and radiation -can be
described as pressure, squeezing, or fullness.
Burning and pleuritic pain may also be
consistent with ACS and may radiate to the
shoulder, arm, neck, jaw, abdomen.
21. Signs/symptoms Cont…
• Palpitation
•Anxiety and fear of impending death.
• fatigue
• nausea and vomiting
• shortness of breath
• cool extremities
-Vague symptoms in elderly, Pregnant or diabetic
patients (e.g., dizziness, syncope, confusion,
symptoms of peripheral emboli, or unexplained
hypotension) may represent silent ischemia.
8/9/2021 By: 1st Yr MSc EMCCN students 21
22. Signs/Symptoms Cont…
Signs
Jugular venous distension
Cool, clammy skin and diaphoresis
Third heart sound(S3)
Apical Systolic Murmur (MR)
Rales-LVD/MR
hypotension or hypertension
• palpable precordial pulse
• muffled heart sounds.
8/9/2021 By: 1st Yr MSc EMCCN students 22
23. Diagnosis/investigation of ACS
History
History is the most sensitive tool for the detection
of ACS, and is a more powerful predictor for
cardiac ischemia than a normal or non-diagnostic
ECG.
A significant number of patients present with
atypical pain or no pain.
-ask about risk factors
Physical examination
GA- Anxious and in considerable distress
HR: Bradycardia to a rapid regular or irregular
tachycardia depending on degree of LV failure.
8/9/2021 By: 1st Yr MSc EMCCN students 23
24. Dx/Ix Cont…
Fever: nonspecific response to tissue necrosis
Tachypnea: -heart failure/results from anxiety
and pain
Blood Pressure:↓ BP
≥50% of patients with inferior STEMI have
evidence of excess parasympathetic
stimulation, with hypotension, bradycardia
LV dysfunction, hypovolemia
◦ ↑BP
50% anterior STEMI show signs of
sympathetic excess and have HTN,
tachycardia, or both.
Murmur(MR) 8/9/2021 By: 1st Yr MSc EMCCN students 24
25. Dx/Ix Cont…
ECG- Should be obtained immediately to identify STEMI.
Other ECG findings indicative of ischemia include ST
depression, T wave inversion.
Cardiac Biomarkers- When myocardial tissue is
damaged, enzymes leak into the vascular space and are
measured in the serum.
-Troponin (Tn)-cardiac specific gold standard elevated
with in 4-6 hours of injury and remain for 3-10 days.
-Differentiation is generally based on 3 sets of biomarkers
measured at 6-8 hours interval after patients presentation
to the ED. Continue measuring markers until peak is
reached or 3 sets of result are negative.
LDH: onset (24hrs) peak (48-72 hrs) return to normal (7-
10days)
Myoglobin- non-specific
8/9/2021 By: 1st Yr MSc EMCCN students 25
26. Dx/Ix Cont…
Creatine kinase (CK) - is found in skeletal and
cardiac muscle. The CK-MB portion is a subunit of
CK and is more specific for myocardial tissue.
CKMB begins to increase 4–6 hours after infarction,
but is return to normal within 24–36 hours.
lipid profile.
Exercise Stress Testing- at least after 24HRs of
stabilization
Echocardiography- ventricular wall motion and LBBB
CXR- For cardiomegaly & pulmonary edema
A widened mediastinum (> 8 cm) causes concern for
an aortic dissection.
CT angiography-may be indicated in patients who are
suspected of having a PE or aortic dissection.
8/9/2021 By: 1st Yr MSc EMCCN students 26
27. DDx
Pulmonary embolism causes sharp, pleuritic, or
dull chest pain with dyspnea and diaphoresis.
Aortic dissection- ripping or tearing sensation
radiating to the interscapular area of the back.
Tension pneumothorax. Patients usually present
with dyspnea accompanied by the signs or
symptoms of shock .
Acute esophageal perforation/rupture- can
cause sharp pleuritic, poorly localized, constant,
and severe midline pain anywhere from the base of
the neck to the epigastrium associated with
systemic signs of infection and bleeding.
Pneumonia is suggested by cough and fever with
or without pleuritic chest pain
8/9/2021 By: 1st Yr MSc EMCCN students 27
28. Management of ACS
Initial Approach/General management
1. Ensure adequate ABCs.
2. Vital signs monitoring
3. Supplemental O2- only when respiratory
distress/symptoms of hypoxemia present.
4. Cardiac monitoring & pulse oximetry.
8/9/2021 By: 1st Yr MSc EMCCN students 28
29. MGT Cont…
Goals of Management
Increase blood flow(oxygen delivery to the
heart)
Decrease oxygen consumption by the
heart
Reduce chest pain
Prevent further damage & future attack
8/9/2021 By: 1st Yr MSc EMCCN students 29
30. MGT Cont…
Pharmacological therapy
Unstable angina/NSTEMI—
Nitrates- sublingual NTG Q5 min, up to 3 minutes,
Iv NTG for persistent ischemia, HF or HTN.
Analgesics- morphine
β-blockers- metoprolol
Calcium channel blockers- nifedipine/amlodipine
when BB are C/I.
ACE inhibitors-Enalapril
Antiplatelet therapy- aspirin
ADP receptor inhibitors-clopidogrel
Anticoagulation- heparin, LMWH
Cholesterol Management- Statins(atorvastatin)
8/9/2021 By: 1st Yr MSc EMCCN students 30
31. MGT Cont…
STEMI—In addition to above therapy:-
Reperfusion therapy
PCI-The artery is dilated using a PTCA balloon
catheter and stent placement.
Fibrinolysis/thrombolysis-Streptokinase, tissue
plasminogen activator (tPA).
Revascularization Therapy
Coronary artery bypass grafting(CABG)
native vessels (conduits) are harvested and
grafted into place to reroute blood flow past
diseased areas of the coronary arteries.
8/9/2021 By: 1st Yr MSc EMCCN students 31
32. Complications
Arrythmia- the most common due to ischemia
Congestive heart failure
Pulmonary edema
Cardiogenic shock.
Pericarditis
8/9/2021 By: 1st Yr MSc EMCCN students 32
33. Disposition & Nursing Management
Admission to Intensive Care Units (ICU)
Oxygen support
IV drug administration
Monitor vital signs
Monitor cardiac function
Neurologic checks
Determine cause and treat
Diet and bowel: Decrease saturated fat & salt
diet.
◦ Small frequent feeding, diet rich in fiber / Stool
softeners
Activity: bed rest for the first 12 h…sitting in a chair within
the first 24 h…day 3-ambulation TID.
8/9/2021 By: 1st Yr MSc EMCCN students 33
34. References
Kaplan USMLE STEP 2 CK internal medicine
lecture notes, 2019.
European society of cardiology(ESC), 2019.
AHA/ACC Guidelines, for the management of
NSTE-ASC, 2016.
Current medical diagnosis and treatment, 2015, 58th
edition.
Tintinali's emergency medicine, 8th edition.
8/9/2021 By: 1st Yr MSc EMCCN students 34